Prospective multicenter study on severe heart failure due to chronic ischemic heart disease

Prospective multicenter study on severe heart failure due to chronic ischemic heart disease - Prospective multicenter study on severe heart failure due to chronic ischemic heart disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000022260

Enrollment

120

Registered

2016-05-16

Start date

2016-05-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe heart failure due to chronic ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ?chronic ischemic heart disease. ?LVEF <35% ?NYHA class 3 or 4. ?Drug therapy with maximal oral medication including digitalis, diuretic, angiotensin-converting enzyme inhibitors, angiotensin 2 receptor blockers, beta-blockers, and diuretics. ?Patients with worsening heart failure after standard treatments (CABG, mitral valvuloplasty, surgical ventricular restoration, CRT, and PCI).

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
Evaluation of the survival rate for the life prognosis	—

Secondary

Measure	Time frame
1) The absence of hospitalization rate due to any serious cardiovascular events. 2) The ratio of 5% or more improvement about LVEF at 6 months after registration.	—

Countries

Japan

Contacts

Public ContactKazuo Tamada

Terumo Corporation Clinical Development Department

Rinshokenkyu_HS@terumo.co.jp03-6742-8500

Outcome results